[Journal logo]

Volume 65 
Part 4 
Page o869  
April 2009  

Received 22 February 2009
Accepted 17 March 2009
Online 25 March 2009

Key indicators
Single-crystal X-ray study
T = 293 K
Mean [sigma](C-C) = 0.004 Å
R = 0.051
wR = 0.141
Data-to-parameter ratio = 14.3
Details
Open access

N-[(E)-2-Chlorobenzylidene]-3-(4-methylbenzylsulfanyl)-5-(3,4,5-trimethoxyphenyl)-4H-1,2,4-triazol-4-amine

aCenter for Research and Development of Fine Chemicals, Guizhou University, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Guiyang 550025, People's Republic of China, and bDepartment of Chemistry, Bijie University, Bijie 551700, People's Republic of China
Correspondence e-mail: qianzhuli77@yahoo.com.cn

In the title compound, C26H25ClN4O3S, the acyclic imine group exhibits an E configuration. The triazole ring is oriented at dihedral angles of 53.84 (2), 70.77 (1) and 32.59 (3)° with respect to the benzene rings of the 2-chlorobenzylidene, 4-methylbenzylsulfanyl and 3,4,5-trimethoxyphenyl groups, respectively. The crystal packing is stabilized by weak intermolecular C-H...N, C-H...S and C-H...[pi] interactions.

Related literature

For more information on 1,2,4-triazoles, see: He et al. (2006[He, X., Lu, C. Z., Wu, C. D. & Chen, L. J. (2006). Eur. J. Inorg. Chem., pp. 2491-2503.]); Kritsanida et al. (2002[Kritsanida, M., Mouroutsou, A., Marakos, P., Pouli, N., Papakonstantinou- Garoufalias, S., Pannecouque, C., Witvrouw, M. & Clercq, E. D. (2002). Farmaco, 57, 253-257.]); Demirbas et al. (2002[Demirbas, N., Ugurluoglu, R. & Demirbas, A. (2002). Bioorg. Med. Chem. 10, 3717-3723.]); Chattopadhyay & Ghosh (1987[Chattopadhyay, S. K. & Ghosh, S. (1987). Inorg. Chim. Acta, 131, 15-20.], 1989[Chattopadhyay, S. K. & Ghosh, S. (1989). Inorg. Chim. Acta, 163, 245-253.]).

[Scheme 1]

Experimental

Crystal data
  • C26H25ClN4O3S

  • Mr = 509.01

  • Monoclinic, P 21 /c

  • a = 11.283 (4) Å

  • b = 7.414 (2) Å

  • c = 31.087 (10) Å

  • [beta] = 100.961 (14)°

  • V = 2553.1 (14) Å3

  • Z = 4

  • Mo K[alpha] radiation

  • [mu] = 0.27 mm-1

  • T = 293 K

  • 0.32 × 0.26 × 0.22 mm

Data collection
  • Bruker APEXII CCD diffractometer

  • Absorption correction: multi-scan (SADABS; Sheldrick, 1996[Sheldrick, G. M. (1996). SADABS. University of Göttingen, Germany.]) Tmin = 0.932, Tmax = 0.956

  • 26288 measured reflections

  • 4590 independent reflections

  • 3809 reflections with I > 2[sigma](I)

  • Rint = 0.028

Refinement
  • R[F2 > 2[sigma](F2)] = 0.051

  • wR(F2) = 0.141

  • S = 1.03

  • 4590 reflections

  • 320 parameters

  • H-atom parameters constrained

  • [Delta][rho]max = 0.50 e Å-3

  • [Delta][rho]min = -0.65 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

D-H...A D-H H...A D...A D-H...A
C19-H19...N4 0.93 2.52 3.000 (3) 112
C10-H10...S1 0.93 2.81 3.184 (3) 105
C6-H6...N1i 0.93 2.61 3.409 (3) 144
C8-H8B...Cg2ii 0.97 2.70 3.427 (2) 133
C24-H24B...Cg1iii 0.96 2.94 3.588 (2) 125
Symmetry codes: (i) -x+1, -y+1, -z; (ii) -x+1, -y+2, -z; (iii) x, y-1, z. Cg1 is the centroid of the C9,C17,N1-N3 ring and Cg2 is the centroid of the C2-C7 ring.

Data collection: APEX2 (Bruker, 2004[Bruker (2004). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: SAINT (Bruker, 2004[Bruker (2004). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.]); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: DIAMOND (Brandenburg, 2001[Brandenburg, K. (2001). DIAMOND. Crystal Impact GbR, Bonn, Germany.]); software used to prepare material for publication: SHELXTL (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]).


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: GK2192 ).


Acknowledgements

The authors acknowledge the National Key Technologies R&D Program of China (2006BAE01A01-13) for supporting this work.

References

Brandenburg, K. (2001). DIAMOND. Crystal Impact GbR, Bonn, Germany.
Bruker (2004). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
Chattopadhyay, S. K. & Ghosh, S. (1987). Inorg. Chim. Acta, 131, 15-20.  [CrossRef] [ChemPort] [ISI]
Chattopadhyay, S. K. & Ghosh, S. (1989). Inorg. Chim. Acta, 163, 245-253.  [CrossRef] [ChemPort] [ISI]
Demirbas, N., Ugurluoglu, R. & Demirbas, A. (2002). Bioorg. Med. Chem. 10, 3717-3723.  [CrossRef] [PubMed] [ChemPort]
He, X., Lu, C. Z., Wu, C. D. & Chen, L. J. (2006). Eur. J. Inorg. Chem., pp. 2491-2503.
Kritsanida, M., Mouroutsou, A., Marakos, P., Pouli, N., Papakonstantinou- Garoufalias, S., Pannecouque, C., Witvrouw, M. & Clercq, E. D. (2002). Farmaco, 57, 253-257.  [CrossRef] [PubMed] [ChemPort]
Sheldrick, G. M. (1996). SADABS. University of Göttingen, Germany.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]


Acta Cryst (2009). E65, o869  [ doi:10.1107/S1600536809009842 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.